Thermo Fisher Scientific announced that it has been awarded the Microsoft Life Sciences Innovation Award for the third consecutive year.
Thermo Fisher Scientific announced that it has been awarded the Microsoft Life Sciences Innovation Award for the third consecutive year. The award recognizes companies for their innovative use of Microsoft-based solutions.
The company was selected together with Emory University, part of the Atlantic Clinical and Translational Science Institute (ACTSI), for the use of LIMS to advance information exchange in the clinical and translational science environment across a diverse set of laboratories.
Michael Naimoli, director of life sciences industry solutions, Microsoft explained more: “The Emory/ACTSI implementation takes advantage of Thermo Scientific WebAccess deployed on Microsoft technologies to deliver rich client functionality via a web browser to both internal and external users. In addition, the Study Design Module created by Thermo Fisher and Emory using Microsoft tools provides an easy to use graphical user interface for study design, which allows the ACTSI to design workflows more quickly.”
The institute is focused on accelerating the translation of laboratory discoveries into healthcare innovations for patients and plays an important role in North American health research by supporting investigators across Emory University, Morehouse School of Medicine, Grady Hospital, Children’s Healthcare of Atlanta and the Georgia Institute of Technology. A key initiative is the selection and deployment of LIMS across the consortium to support a “virtual bio-repository” environment.
For more information visit www.thermoscientific.com/awards
Evaluating Antimicrobial Potential of Articaine Derivatives in Oral Infections with CMC
May 20th 2025Cell membrane chromatography (CMC) technology was used by researchers in screening efficacy and antibacterial ability of articaine (AT) derivatives in the pre-emptive treatment of oral infections.
Hydrophilic Interaction Chromatography (HILIC) and Direct Online Disruption of Lipid Nanoparticles
May 19th 2025Two proof-of-concept hydrophilic interaction chromatography HILIC) methods were developed in a joint study conducted by the University of Geneva (Switzerland), Sanofi, and the Waters Corporation—one for disrupting LNPs and retaining the mRNA, and another for detecting only unencapsulated mRNA to assess encapsulation efficiency. LCGC International spoke to Jonathan Maurer, first author of the paper that resulted from this study, about the methods and the efforts that led up to their development.
This article discusses how integrating seven prioritization strategies can enhance compound identification, support environmental risk assessment, and accelerate decision-making.